The association of sudden cardiac death with inflammation and other traditional risk factors

Kidney International

Volumn 74, Issue 10, 2008, Pages 1335-1342

  Parekh, Rulan S ^a,b,c   Plantinga, Laura C ^b,c   Kao, W H Linda ^b,c   Meoni, Lucy A ^a,b,c   Jaar, Bernard G ^a,b,c   Fink, Nancy E ^a,b,c   Powe, Neil R ^a,b,c   Coresh, Josef ^a,b,c   Klag, Michael J ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cohort study; Inflammation; Mortality; Sudden death

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIALYSIS; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; C-REACTIVE PROTEIN; CAUSE OF DEATH; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN;

EID: 55249101446     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.449     Document Type: Article

References (49)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998; 32: S112-S119.
2. U.S. Renal Data System, USRDS 2004 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, USA, 2004.
3. Herzog CA. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol 2005; 25: 363-366.
4. Herzog CA. Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2007; 2: 410-412.
5. Herzog CA, Li S, Weinhandl ED et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68: 818-825.
6. Zheng ZJ, Croft JB, Giles WH et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-2163.
7. Herzog CA. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int Suppl 2003; 84: S197-S200.
8. Cheung AK, Sarnak MJ, Yan G et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65: 2380-2389.
9. Karnik JA, Young BS, Lew NL et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350-357.
10. Paoletti E, Specchia C, Di Maio G et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834.
11. Takeda K, Harada A, Okuda S et al. Sudden death in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 952-955.
12. Shehab AM, MacFadyen RJ, McLaren M et al. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 2004; 90: 1263-1268.
13. Mukamal KJ, Tolstrup JS, Friberg J et al. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol 2006; 98: 75-81.
14. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248.
15. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2001; 19: 53-61.
16. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
17. Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens 2000; 9: 621-630.
18. Wang TJ, Larson MG, Levy D et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002; 106: 1189-1191.
19. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414.
20. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001; 56: 375-380.
21. Albert CM, Ma J, Rifai N et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595-2599.
22. Ridker PM, Buring JE, Shih J et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733.
23. Ridker PM, Cushman M, Stampfer MJ et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-428.
24. Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 1998; 46: 391-395.
25. Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
26. Hoffman BF, Feinmark SJ, Guo SD. Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. J Cardiovasc Electrophysiol 1997; 8: 679-687.
27. Hoffman BF, Guo SD, Feinmark SJ. Arrhythmias caused by platelet activating factor. J Cardiovasc Electrophysiol 1996; 7: 120-133.
28. Rubinger D, Revis N, Pollak A et al. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 2004; 19: 2053-2060.
29. Dursun B, Demircioglu F, Varan HI et al. Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study. Ren Fail 2004; 26: 35-38.
30. Karayaylali I, San M, Kudaiberdieva G et al. Heart rate variability, left ventricular functions, and cardiac autonomic neuropathy in patients undergoing chronic hemodialysis. Ren Fail 2003; 25: 845-853.
31. Fukuta H, Hayano J, Ishihara S et al. Prognostic value of nonlinear heart rate dynamics in hemodialysis patients with coronary artery disease. Kidney Int 2003; 64: 641-648.
32. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003; 108: 1772-1778.
33. Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001; 12: 369-381.
34. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117.
35. Parekh RS, Zhang L, Fivush BA et al. Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: a sample of the US ESRD population. J Am Soc Nephrol 2005; 16: 1420-1426.
36. Albert CM, Chae CU, Grodstein F et al. Prospective study of sudden cardiac death among women in the United States. Circulation 2003; 107: 2096-2101.
37. Pun PH, Lehrich RW, Smith SR et al. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2007; 2: 491-500.
38. Anderson RN, Minino AM, Hoyert DL et al. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001; 49: 1-32.
39. Bleyer AJ, Hartman J, Brannon PC et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69: 2268-2273.
40. Fonarow GC, Horwich TB. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 2003; 4(Suppl 4): S20-S28.
41. Iliou MC, Fumeron C, Benoit MO et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis 2003; 42: 513-523.
42. Longenecker JC, Coresh J, Klag MJ et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000; 11: 520-529.
43. Longenecker JC, Coresh J, Powe NR et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927.
44. Miskulin DC, Meyer KB, Athienites NV et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39: 324-336.
45. Zheng Z, Croft JB, Giles WH et al. State-specific mortality from sudden cardiac death: United States, 1999. MMWR Morb Mortal Wkly Rep 2002; 51: 123-126.
46. Prentice RL, Kalbfleisch JD, Peterson Jr AV et al. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34: 541-554.
47. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524-532.
48. Choudhury JB. Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Stat Med 2002; 21: 1129-1144.
49. Liu Y, Coresh J, Eustace JA et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004; 291: 451-459.